Science And Medicine открытые
[search 0]
Больше
Download the App!
show episodes
 
Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus.
  continue reading
 
Some of the world's greatest scientists, doctors and medical researchers share their discoveries and visions onstage at the TED conference, TEDx events and partner events around the world. You can also download these and many other videos free on TED.com, with an interactive English transcript and subtitles in up to 80 languages. TED is a nonprofit devoted to Ideas Worth Spreading.
  continue reading
 
Artwork

1
Women in Science and Medicine Podcast

Women in Science and Medicine

Unsubscribe
Unsubscribe
Ежемесячно
 
The Women in Science and Medicine podcast features discussions with female scientists within West Virginia University and other institutions. In this series, we’ll share the achievements and insights from some of the country’s top female scientists and learn from their experiences to understand how they came to be passionate about science and overcame any obstacles in their paths. This podcast is offered by West Virginia University’s Office of Research and Graduate Education.
  continue reading
 
Loading …
show series
 
Join Dr. Anna Wolska and Dr. Jim Posada as they delve into the intricacies of RNAse therapy in the management of Systemic Lupus Erythematosus (SLE). In this podcast episode, Dr. Posada describes the groundbreaking study evaluating the efficacy of RSLV-132, a novel RNAse molecule fused to human IgG1 Fc, in reducing chronic inflammation associated wi…
  continue reading
 
Dr. Anna Wolska engages in a conversation with Dr. Shivani Garg and Dr. Christie Bartels to delve into the development and implementation of HCQ-SAFE. This innovative decision-aid is designed to empower individuals living with lupus to engage in shared-decision making. The authors discuss the importance of streamlining and enhancing shared decision…
  continue reading
 
In the US, every 12 hours a woman dies due to complications resulting from pregnancy. Additionally, 2 babies die each day. According to data from the national center for health statistics the maternal mortality rate for 2021 was 32.9 deaths per 100,000 live births, compared with a rate of 23.8 in 2020 and 20.1 in 2019 In 2021, the maternal mortalit…
  continue reading
 
In the US, every 12 hours a woman dies due to complications resulting from pregnancy. Additionally, 2 babies die each day. According to data from the national center for health statistics the maternal mortality rate for 2021 was 32.9 deaths per 100,000 live births, compared with a rate of 23.8 in 2020 and 20.1 in 2019 In 2021, the maternal mortalit…
  continue reading
 
In the US, every 12 hours a woman dies due to complications resulting from pregnancy. Additionally, 2 babies die each day. According to data from the national center for health statistics the maternal mortality rate for 2021 was 32.9 deaths per 100,000 live births, compared with a rate of 23.8 in 2020 and 20.1 in 2019 In 2021, the maternal mortalit…
  continue reading
 
Dr. Anna Wolska speaks to Dr. Michael Belmont and Devyn Zaminski to discuss the importance of dual dsDNA testing in order to full understand disease activity. In this study, they made the observation that there is a large amount of discordance in anti-dsDNA antibodies assays. Misinterpretation or errors in anti- dsDNA antibody testing could have ne…
  continue reading
 
The WISM podcast returns with one of WVU’s very own! Mallory chats with Dr. Savannah Sims, a graduate of the Biomedical Sciences Ph.D. program. She’s a passionate advocate of STEM and directed her career towards that aim. Dr. Sims relates inspiring and practical advice around finding your passion as a scientist, pushing against your comfort barrier…
  continue reading
 
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus neph…
  continue reading
 
Dr. Anna Wolska sits down with experts, Dr. Michelle Petri and Dr. Nick Ballew, analyzing the effectiveness of SLE treatments Belimumab and Anifrolumab. The conversation delves into their meticulous study, where they examined the 52-week SLE Responder Index (SRI)-4 responses, providing crucial data for informed lupus patient care. The study data, b…
  continue reading
 
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Ana Malvar and Brad Rovin. They discuss using repeat tissue biopsies to understand progression of lupus nephritis over time. They offer conjecture that both immunosuppression as well as mitigation of tissue fibrosis, resulting from inflammatory resolution, are needed in order to p…
  continue reading
 
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Anca Askanase and Joan Merrill, the developers of the LFA-REAL tool. Together, they discuss the importance of using a tool like LFA-REAL to understand how clinician and patient reported outcomes are essential for understanding efficacy and effectiveness of experimental therapeutic…
  continue reading
 
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Amrie Grammer and Dr. Peter Lipsky from AMPEL BioSolutions. Together they describe the molecular endotypes of Type 1 and Type 2 Systemic Lupus Erythematosus. This episode uncovers the distinct molecular profiles of these SLE types and paves the way for personalized treatment approa…
  continue reading
 
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discusses the time to onset of clinical response to Anifrolumab in patients with Systemic Lupus Erythematosus. The episode delves into pooled data from two significant Phase III trials, TULIP-1 and TULIP-2, offering l…
  continue reading
 
Mallory sits down with Dr. Carrie Shaffer, Assistant Professor in the Veterinary Science, Pharmaceutical Sciences, and Microbiology, Immunology and Molecular Genetics Departments at the University of Kentucky. They discuss her passionate pursuit of science from a very early age, some of the unique characteristics and duties of land grant institutio…
  continue reading
 
What if we could use brain waves to treat Alzheimer's? Professor and neuroscientist Li-Huei Tsai details a promising new approach to artificially stimulate gamma brain waves using light and sound therapy, to increase connectivity and synchrony and delay the onset of this deadly disease. This non-invasive therapy has already been shown to work in mi…
  continue reading
 
Could the next wonder drug be somewhere in Canada's snowy north? Take a trip to this beautiful, frigid landscape as chemist Normand Voyer explores the mysterious molecular treasures found in plants thriving in the cold. These scarcely investigated organisms could hold immense medical promise, he says – so long as we work quickly enough to discover …
  continue reading
 
Could the next wonder drug be somewhere in Canada's snowy north? Take a trip to this beautiful, frigid landscape as chemist Normand Voyer explores the mysterious molecular treasures found in plants thriving in the cold. These scarcely investigated organisms could hold immense medical promise, he says – so long as we work quickly enough to discover …
  continue reading
 
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in urinary CD163 levels and the response to Belimumab treatment in Lupus Nephritis trials. The conversation provides important insights…
  continue reading
 
As Arctic ice melts, polar bears are being forced on land -- and they're hungry. With the apex predators frequently turning to human junkyards for a snack, northern towns have had to get creative in order to keep both their people and wildlife safe. Biologist and conservationist Alysa McCall shares lessons from the field on how to safely navigate c…
  continue reading
 
As Arctic ice melts, polar bears are being forced on land -- and they're hungry. With the apex predators frequently turning to human junkyards for a snack, northern towns have had to get creative in order to keep both their people and wildlife safe. Biologist and conservationist Alysa McCall shares lessons from the field on how to safely navigate c…
  continue reading
 
Amy Lehman is Founder and CEO at Lake Tanganyika Floating Health Clinic, an international organization, whose mission is to address the problem of healthcare access for millions of people who live in the isolated, but strategically critical lake, Tanganyika, great lakes region of central Africa. She received both an MD and MBA from the University o…
  continue reading
 
Nkem Egekeze is chief innovation officer and Managing Director of Stealth Startup. He previously worked as an orthopedic surgery resident and as a research scholar at the University of Georgia, and a strategy advisor at Harvard Innovation Labs. He obtained his medical degree from University of Michigan medical school. He focuses on providing value-…
  continue reading
 
Veronica O’Keane has recently retired from her position which was as a professor of psychiatry and consultant psychiatrist at Trinity College Dublin. She has over 30 years of experience in the field and has published numerous research papers, especially on mood disorders and on perinatal depression. She is the author of the book A Sense of Self: Me…
  continue reading
 
Maneesha Ghiya is Managing Partner and Founder of FemHealth Ventures, a firm focused on providing investment capital to entrepreneurs focused on women’s health. Investing in healthcare since 2000, Maneesha has invested via public equities, private equities and as a hedge fund specialist. She is a Senior Advisor to ExSight Ventures, an ophthalmology…
  continue reading
 
In Series 2 of our Inspiring People in Medicine and Science we continue to source inspiring voices and to ventilate topics relevant to us, our loved ones and the societies we live in. With topics as wide ranging as development aid, mental health, Femhealth and value – we dig deep into what these areas mean, why the conventional wisdom is not always…
  continue reading
 
Meet the fantastically colorful and astonishingly adaptable sea slugs that found a way to photosynthesize (or create energy from sunlight) like plants. Diving deep into these often overlooked creatures, invertebrate zoologist Michael Middlebrooks introduces the solar-powered slugs that lost their shells -- but gained the ability to directly harness…
  continue reading
 
Meet the fantastically colorful and astonishingly adaptable sea slugs that found a way to photosynthesize (or create energy from sunlight) like plants. Diving deep into these often overlooked creatures, invertebrate zoologist Michael Middlebrooks introduces the solar-powered slugs that lost their shells -- but gained the ability to directly harness…
  continue reading
 
Shalom Lloyd, after a career of over 20 years in the pharmaceutical industry, went on to found two businesses. She is founder of Naturally Tribal skincare, a beauty line based on traditional remedies including shea butter, which she developed initially to cure her son’s eczema. She is also the co-founder and Chief Strategy Officer of eMQT, describe…
  continue reading
 
Our memories and bodies give us clues about who we are, but what happens when this guidance shifts? In this mind-bending talk, science writer Anil Ananthaswamy shares how the experiences of "altered selves" -- resulting from schizophrenia, Alzheimer's, foreign limb syndrome or other conditions -- shed light on the constructed nature of identity. He…
  continue reading
 
Our memories and bodies give us clues about who we are, but what happens when this guidance shifts? In this mind-bending talk, science writer Anil Ananthaswamy shares how the experiences of "altered selves" -- resulting from schizophrenia, Alzheimer's, foreign limb syndrome or other conditions -- shed light on the constructed nature of identity. He…
  continue reading
 
Farming is the worst thing humanity has ever done to the planet, says journalist George Monbiot. What's more: the global food system could be heading toward collapse. Detailing the technological solutions we need to radically reshape food production -- from lab-grown, protein-rich foods to crops that don't require plowing -- Monbiot shares a future…
  continue reading
 
Farming is the worst thing humanity has ever done to the planet, says journalist George Monbiot. What's more: the global food system could be heading toward collapse. Detailing the technological solutions we need to radically reshape food production -- from lab-grown, protein-rich foods to crops that don't require plowing -- Monbiot shares a future…
  continue reading
 
If we want to better understand the environment and combat climate change, we need to look deep underground, where diverse microscopic fungal networks mingle with tree roots to form symbiotic partnerships, says microbiologist Colin Averill. As we learn more about which of these fungi are most beneficial to forest health, we can reintroduce them int…
  continue reading
 
If we want to better understand the environment and combat climate change, we need to look deep underground, where diverse microscopic fungal networks mingle with tree roots to form symbiotic partnerships, says microbiologist Colin Averill. As we learn more about which of these fungi are most beneficial to forest health, we can reintroduce them int…
  continue reading
 
Loading …

Краткое руководство